Patient Stories

Treatment for Multiple Myeloma at Emory – Real Patient Story

Meet these real-life Multiple myeloma patients and learn about treatment for Multiple Myeloma at EmoryWhen Cathy Mooney was first diagnosed with multiple myeloma, the myeloma program at Winship was just beginning to take off. Today, the center provides treatment for multiple myeloma to 400 to 500 new patients a year, with about 1,600 multiple myeloma patients overall. More than 200 Winship patients participate in the Phase I Clinical Trials Unit directed by Donald Harvey.

“That’s a huge group that we are able to see in one city,” says Ajay Nooka, assistant professor of hematology and medical oncology and part of the hematology care team at Winship. In addition to caring for patients, Nooka, who specializes in cancer epidemiology, structures and oversees many of Winship’s clinical trials and assesses their outcomes.

The large patient population and high rate of clinical trial enrollment is a gold mine of data for researchers.

“The ultimate goal is to see where we stand in terms of treatment for multiple myeloma progress and what changes we can make to further improvements in patient outcomes,” Nooka says.
Another advantage for Winship’s multiple myeloma team is Atlanta’s large population of African Americans, who are twice as likely as the white population to be diagnosed with the disease.

“The difference between us and other centers is that a lot of our patients are our neighbors,” Lonial says. “A lot of the game in clinical trials is not just, are you able to do them, but do you have the patients? The growth for us has stemmed from access to new drugs and access to patients. That’s a big reason why we had four drugs approved last year as a part of treatment for multiple myeloma.”

In November, the FDA approved elotuzumab as part of an innovative immune-based therapy treatment for patients with relapsed multiple myeloma. That was the third myeloma drug approved by the FDA within the previous month and the fourth approved within the last year.

That’s good news for patients like Quincy Washington, who was 42 when he was diagnosed with multiple myeloma in 2007.

At first his doctor suspected rheumatoid arthritis, but then sent Washington to an oncologist, where he learned about myeloma for the first time. The disease typically strikes African American men at a younger age than any other patient group.

“The doctor said, you have multiple myeloma. I said, okay. What do we do next?” Washington remembers. “She looked at my wife and said, is he in shock? And my wife said no, that’s pretty much his personality. I don’t really do the whole gloom-and-doom perspective.”

Washington happened to have a friend who specializes in oncology at Winship, and that’s how he discovered that he could get the most leading-edge care within miles of his home in Lithonia. He began treatment for multiple myeloma immediately, including enrollment in a clinical trial.

Now in long-term remission, Washington says, “My plan is to be cured. At some point, my numbers will be zero. When it comes to age, I’m a triple-digit kind of guy.”

Treatment for Multiple Myeloma at Emory – Real Patient Story

myeloma_mooney_coverCathy Mooney shares her multiple myeloma patient story. Treatment for multiple myeloma is the topic very relevant to even those who consider themselves a “health nut” or a “gym rat”. This article shares a story of how one health-conscious young lady had to undergo a treatment for multiple myeloma at Emory.

Cathy Mooney didn’t need a wake-up call. In 2002, at 48 years old, “I felt like I was at the top of my game,” she says. “I was exercising regularly, walking four miles five days a week. I was following a great diet. I had really never been in better health.” But a routine physical exam turned up some troubling results, and a long series of visits to specialists and tests followed. After a frustrating three months, Mooney heard two words she never knew before: multiple myeloma.

“I learned that the survival rate was three to five years,” she says. “We were devastated. I felt wonderful; I did not feel sick.” Mooney received an advise to travel from her home in Thomasville, Georgia, to Little Rock, Arkansas. There was a center specializing in myeloma.

For several years she received the following treatment there:

  • chemotherapy
  • autologous stem cell transplantation
  • maintenance medications

Although her cancer could be coaxed into remission, it kept coming back.

In 2008, Mooney and her husband flew north to visit myeloma specialists at Sloan Kettering and the Dana-Farber Cancer Institute. The latter was Ken Anderson, who had been following Lonial’s progress at Winship. Both told Mooney that she could get the best, most current treatment in her home state of Georgia.

“When we went to Emory and met with Dr. Lonial and his team, we found him to be a compassionate person who cared and was passionate about finding a cure for multiple myeloma,” Mooney says. “He’s such a respected doctor in this field, one of the top in leading research and a rising star.”

Since Mooney’s diagnosis, her twin daughter and son have married and had children of their own. Her five grandchildren are a constant delight.

“This year was 14 years since my diagnosis, which is a lot more than I hoped for,” she says. “I’m feeling great. The cancer has given me an opportunity to reassess my life and set new priorities. And Winship gives me hope for a bright future.”

Multiple Myeloma Symptoms & Treatment – Real Patient Story

Meet Emory's real Multiple myeloma patient and learn about Multiple myeloma symptoms and treatment optionsMultiple myeloma begins in the bone marrow with plasma cells going haywire. This article shares a multiple myeloma patient story, as well as discusses symptoms and treatment options.
Seven years ago, Tamara Mobley was so busy, active, and energetic that if she were a cartoon, she’d be a blur. The dedicated mother of two young boys, a loving wife and a full-time employee in a good job, she didn’t get much downtime.

“I think I was just busy, like any other typical mom,” Mobley says. “You know, just doing things to take care of the house, my family and doing my best to be a valued employee. That was my life before, just ripping and running.”

Then Mobley, who was 33, got tired. Not just garden-variety, too-little-sleep, I’ve-been-doing-too-much sort of tired. But bone tired, from the moment she woke up each morning. Then, there was the severe back pain. And then, the passing out. She was getting sick and it was happening fast. For a young, vibrant, working wife and mother that was terrifying.

A trip to the emergency room led to a rapid diagnosis of multiple myeloma — a cancer of the blood — and a recommendation from her doctor to seek treatment at Emory and Winship.
Mobley was so ill that she got to Emory University Hospital in an ambulance. And that’s when all the ripping and running slowed way, way down — at least for a while.

Multiple Myeloma Symptoms

As cancer goes, multiple myeloma is a bit of a misfit.

For one thing, it’s rare. The American Cancer Society estimates that about 30,000 new cases of myeloma will be diagnosed this year, trailing far behind the most common cancers — breast and lung — each of which will derail more than 220,000 lives. That’s stiff competition for research funding and awareness.

For another, it’s mysterious. Multiple myeloma begins in the bone marrow with plasma cells going haywire. But experts aren’t entirely sure how the process starts or what the key risk factors are. The disease is most common in people over 65, men are slightly more vulnerable and that African Americans are more than twice as likely as white Americans to get it. But we don’t know why.
The most notable differ
ence between multiple myeloma and pretty much all other types of cancer is that the life expectancy for myeloma patients has doubled in the past decade. All thanks to treatments developed and tested at Emory’s Winship Cancer Institute.

Multiple Myeloma Treatment

Last November, the US Food and Drug Administration (FDA) approved the fourth new myeloma drug to be green-lighted within one year —three of those within one monthv—and all four were tested in clinical trials at Winship.

“There’s no other story like that in cancer,” says Sagar Lonial, Winship’s chief medical officer and chair of the Department of Hematology and Medical Oncology in the School of Medicine.
Since his arrival at Emory and Winship in 1997, Lonial has built the multiple myeloma program into one of the best and most sought-after in the country. A team of experts who specialize in the disease leads this program. As Georgia’s only National Cancer Institute–designated cancer center and one of just 69 in the US, Winship offers patients the chance to be treated in the same building where research is taking place. There are three floors dedicated to basic science and three to clinical care.

“That marriage of research and patient care is powerful,” Lonial says. “Our scientists see cancer patients every day.”

One of those is Mobley, who has been in treatment at Winship since that devastating ambulance ride in 2009. Once her condition was stabilized, she began the standard protocol. It consists of a three-pronged attack:

  • Chemotherapy to blast away the cancerous cells
  • Stem cell harvesting and transplantation to regenerate healthy bone marrow cells
  • Regimen of medications calibrated to keep the cancer at bay and send it into remission for a long time.

It’s that last phase that has put Winship’s approach ahead of other myeloma treatment centers. Instead of a one-by-one, trial-and-error approach to drug therapy, Lonial has advocated a full court press. It allowed to hit the residual cancer with a simultaneous three-drug combination.

Mobley was put on an aggressive course of therapy made up of

  • Lenolidamide (Revlimid), an immune modulator
  • Bortezomib (Velcade), a proteasome inhibitor
  • Dexamethasone, a corticosteroid

“That concept of combination therapy is one that our center is focused on and one that benefited her early on,” Lonial says.

According to myeloma researcher Lawrence Boise, Georgia Cancer Coalition Distinguished Cancer Scholar and coleader of the Cancer Cell Biology Program at Winship, scientists are finding that there are many reasons for this. But the most compelling is that it works. “Dr. Lonial doesn’t leave any bullets in the chamber,” Boise says. “In all the trials, all the data, all the comparisons show that three drugs are better than two.”

When Lonial joined Emory’s hematology and oncology department nearly two decades ago, other researchers might have seen a department struggling with turnover and inadequate resources. With the encouragement of a mentor—Kenneth Anderson, probably the best-known myeloma specialist in the world—Lonial saw an opportunity to build a program, from the ground up.

The bottom floor of Winship houses the Clinical Trials Unit, the key to the multiple myeloma program’s growth and success. Within a few years, Lonial had recruited top scientists and clinicians, including Boise, and was testing new classes of drugs in Phase I clinical trials. They proved to be game changers.

Multiple myeloma is a cancer of the blood that develops when normal, antibody-producing plasma cells become malignant and their growth spirals out of control. They build up in the bone marrow until they crowd out healthy blood cells. They can form lesions and tumors in multiple bones, hence the condition’s name.

But the cancerous cells also secrete protein and, like normal cells, they’re engineered to do this in a particular way—the protein assembled and folded just so. When that assembly goes awry, as it does in myeloma cells, the malformed proteins are broken down by proteasomes—protein complexes whose job it is to get rid of problem proteins by degrading them—and that opens up the pipeline for more myeloma cell production.

About ten years ago, scientists discovered that if you interfere with the proteasome’s work—allowing the abnormal proteins to accumulate—the cancerous cells, which in a sense are trying to function normally, will self-destruct. Rapidly.

“Proteasome is part of quality control, so if you inhibit that, and all these mid-folded proteins build up, that causes stress, and the cell kills itself,” Boise explains.

Winship conducted trials of a promising proteasome inhibitor, bortezomib (Velcade), in 2002. One of the first patients to receive it went into remission quickly. “If there was a moment when the light went on, it was then. I remember running upstairs to the director’s office with the graph of this patient’s counts,” Lonial says. “That treatment is now the standard of care.”

Learn more about Tamara’s story here.

Eric Berry credits Emory nurse as the “real MVP” of his treatment

KCTV5

When Eric Berry first learned he had a type of blood cancer known as Hodgkin lymphoma, the Kansas City Chiefs football player returned to his home and family in Georgia and sought treatment at Winship Cancer Institute. Berry became a patient of Dr. Christopher R. Flowers, a Winship hematologist specializing in lymphoma and director of the Emory Lymphoma Program, and started regular chemotherapy treatments at Winship that lasted for several months. During that time, nurse Stephanie Jones took care of Berry and got to know both him and his family. It turned out that nurse Stephanie made quite a lasting impression on Berry. At the end of July, he returned to Kansas City to resume practices with his team and during his first press conference, he gave a shout-out to Jones and credited her as being the “real MVP” of his treatment. Jones says she’s proud of the honor and admiring of Berry’s determination to beat the cancer. Winship is fortunate to have a dedicated oncology nursing staff that demonstrates patient- and family-centered commitment, care and collaboration. All Winship nurses are specially trained to administer complicated chemotherapy regimens and implement steps for symptom management. As Stephanie shows, our Winship compassion is what is remembered.

See Eric Berry and Stephanie’s story on KCTV-TV Kansas City.

Learn more about Winship Cancer Institute of Emory University.

With a Little Help from Friends

lex gilbert cancer survivorI always assumed that cancer would catch up with me one day. After all, my mother and two of my aunts had breast cancer so I figured I must be next in line. Yet it never occurred to me that the rectal bleeding I’d been experiencing could be colon cancer. Surely the sigmoidoscopy ordered by my doctor would lead me to a quick fix and that would be that. Surprise! When I woke up after the procedure, she came to my bedside and told me I had colon cancer.

When I heard those words I went numb. The world looked as it might if viewed through a funhouse mirror. I remember someone standing nearby handing me a box of Kleenex. I didn’t need the Kleenex. I didn’t cry until many weeks later and boy did I need Kleenex then. I think my soul just closed up shop so it could absorb the gravity of my situation at its own pace, and when it was ready to let go of the emotions, it let go.

Believe me, I am not one of those survivors who talk about what a gift it was to have cancer! I certainly would have preferred to learn the lessons taught by cancer in a less painful way, but all things being equal, there were important lessons learned and I think they are clearly worth passing along. Here’s one.

I pride myself on being self-sufficient and independent. One of the most difficult aspects of being a patient was accepting help from friends. When they offered, I’d say that we didn’t need anything even though that was utterly and completely false. Husbands come in handy sometimes and mine immediately jumped on my reluctance to let folks “in.” At the same time, a dear friend and colleague set up an on-line calendar where I could post what I needed and friends could sign up to help. I could ask for someone to buy me groceries on Wednesday, or help me get the house in order on Saturday, or mow the lawn, drive me to an appointment, or just plain keep me company.

The overwhelming response to the calendar and the ensuing discussions made me realize that when people offer help, they want to help! What a revelation! Too many of us deny our friends the satisfaction and fulfillment that helping someone in need gives them. Allowing folks to help also brings them into our lives in a deeper way, resulting in even more satisfying friendships. The Jedi mind-trick is that letting people help is a gift to them, as well as a gift to you.

About Lex Gilbert

Lex Gilbert is a cancer survivor and very active volunteer with Winship Cancer Institute. She originally comes from southern California, where she ran her own marketing and promotions company serving major corporate clients from throughout the U.S. She has been a life-long volunteer and was awarded “top volunteer” by the County of San Diego for her work mentoring a child in foster care. She moved to Atlanta in 2007 and now works in the Office of Health Promotion at Emory. She was awarded the CLASS Distinguished Service Honor in the Division of Campus Life. Bruce Gilbert, her husband of 32 years, is a musician fighting Parkinson’s disease and also volunteers at Winship as a pianist.

Related Resources

Colon Cancer Chat Transcript

An Intro to Colorectal Cancer Part I: Risk Factors, Symptoms & Diagnosis

An Intro to Colorectal Cancer Part II: Prevention, Diagnosis & Treatment

Winship Cancer Institute – Colon Cancer Resources

Find a primary physician through our Emory Healthcare Network or call Health Connection at 404-778-7777 to learn more from a registered nurse.

5,000-Mile Bone Marrow Transplant Connection

Bone Marrow Transplant Donor

I just celebrated the 5th anniversary of my bone marrow transplant, and I can’t believe it’s been 5 years. In some ways, it feels like yesterday, but in other ways, it seems like forever ago when I first learned that I would need a life-saving transplant …

I was diagnosed with Acute Myelogenous Leukemia (AML) in 2007, and I underwent six rounds of chemotherapy, which thankfully, resulted in remission. To celebrate the journey and one year of remission, my family and I planned a trip to England, Ireland, Scotland, and Wales. We were so excited to celebrate! We planned to leave on a Sunday in June, and I had one more appointment on the Friday before we left. At that appointment, I found out I had relapsed; the leukemia was back. Absolutely devastated, we decided to postpone the trip and start treatment right away instead.

I was evaluated for a bone marrow transplant, and they found a perfect match who was available and willing to donate. By God’s grace, I received my transplant on August 15, 2009. All I knew at that point was that my donor was male, 21 years old, and from another country. I remember writing him a card and sending it through the Be The Match organization to let him know how my recovery was going. Because he was an international donor, we couldn’t exchange information for two years. After two long years of anonymous letters, my donor Johannes and I were able to learn each other’s names and locations. We immediately made contact and began emailing. It was so incredible to be able to talk with the man who saved my life! How could I even begin to put my gratitude into words?!

My family and I decided to re-schedule the trip we had postponed for summer 2012, and we couldn’t wait to finally go – we had so much more to celebrate! That trip was symbolic of God’s healing and grace, and it became even more significant when Johannes and his dad agreed to meet us in London to spend a few days together.

It was an experience of a lifetime! There I was, sitting in a London pub, anxiously awaiting the arrival of the man who gave me the gift of life. It was so amazing to spend a few days exploring London with Johannes and his dad Bernd. God is so good – He healed me and blessed me with two new family members from Germany. What an incredible gift!

Fast forward three years, a dozen Skype sessions, tons of emails, and countless postcards – Johannes surprised me with the news that he and his girlfriend Tina were coming to Georgia to celebrate the 5-year anniversary of my transplant — I call it my transplantiversary. They arrived on Aug. 15 and we spent the weekend camping out at Lake Lanier with friends and family. I loved every minute of it!

We also took Johannes and Tina to tour Winship and meet some of my doctors and practitioners, which was an amazing experience. We went to the hospital and showed Johannes around the unit where I spent so much of my time surrounding the transplant. God is so faithful – it felt like I had come full circle to be able to return to Emory with my donor and celebrate complete healing. What a beautiful experience!

I will forever be connected to Johannes and his family, and it is all because he joined the bone marrow registry in Germany. Through God’s grace, Johannes gave me the gift of life, for which I could never fully express my gratitude. My prayer and my hope is that others will be inspired to join the registry as well – there are so many people who need this life-saving gift, and you could be the match for them! The registration requires a simple cheek swab, and you can request a kit at BetheMatch.org. You, too, could save a life!

About Erin Blonshine

Erin Blonshine lives in Gwinnett County and works as a hospital teacher in the School Program at Children’s Healthcare of Atlanta at Egleston. She felt called to work with children and families experiencing challenges similar to her own. Erin feels blessed by the unique opportunity to serve others in her role at CHOA.
Erin enjoys spending time with her family, including her one month old niece and her two-and-a-half year old nephew. She also loves to travel, hang out with her friends, and relax at Lake Burton.

Related Resources

Bone Marrow Transplant Patient Story: Georgia Teacher Finds Perfect Match Across the Globe

Clinical Trials Responsible for Advances in Medical Treatment

Tamara Mobley, 38 and married with 8 and 12 year old sons, has been battling multiple myeloma for five years now under the care of Dr. Sagar Lonial at the Winship Cancer Institute of Emory University. She went on a clinical trial at Winship in order to get the most advanced drug for treating this blood cancer. Because of that trial, the drug is now FDA-approved and is helping Tamara maintain her active life.

Clinical trials are responsible for most advances in medical treatment, but they can’t take place without volunteer participants like Tamara. Unfortunately, there are still many misconceptions about clinical trials that keep people from participating.

For instance, some believe joining a clinical trial is a last resort in the treatment process, which was not the case for Tamara and many other Winship patients. For Tamara, enrolling in a clinical trial was a good option once her standard cancer drugs stopped working.

In the video below, Fox 5 Atlanta talked to Tamara and Dr. Lonial about the decision to participate in a clinical trial.

Atlanta News, Weather, Traffic, and Sports | FOX 5

It is important to speak with your physician about participating in a clinical trial. For more information about a specific trial, please contact the lead research coordinator.

Related Resources

Growing Hope Together!

Mary BrookhartI was diagnosed with breast cancer at the young age of 33. A cancer diagnosis always comes as a shock, but it’s particularly unexpected at that age. Because my mother had breast cancer at a young age, a new provider sent me for my base line screening mammogram and that turned out to be my first and only mammogram. I can say without a doubt that a mammogram saved my life.

I was treated here at Winship, by Dr. Toncred Styblo and Dr. David Lawson. Twenty-five years later, all three of us are still here. I came back to Winship six years ago, but not as a patient. I took a job as supervisor of business operations for the Glenn Family Breast Center at Winship, and I am one of the organizers of the Celebration of Living event coming up this Sat., June 21.

That’s why the Celebration of Living event is so near and dear to my heart. This is a chance to get together with other survivors, and discover that part of being a survivor is learning that it’s ok to let fun and humor back into your life. Learn to let the fear go and not let it rule your life. Coming to the Celebration of Living event can be a first step toward getting back out into the world, or it can be a continuation of your on-going journey. We all know that battling cancer has very dark moments, but I hope we can bring some hope and lightness into your life.

So I invite all cancer survivors, their family members and friends to come share this special day. There will be workshops for the mind, body and soul, as well as music, food and companionship. It’s free and open to all. Detailed information is available on our website.

I see more and more people surviving cancer because of new and better treatments and earlier detection. In the time since I got my screening mammogram, the technology has greatly improved. Emory and Winship are now offering state-of-the-art 3D mammograms (also called tomosynthesis) at no additional charge above the cost of standard mammograms, so that all women can benefit from this more precise screening technology. For more information about this new service and where it’s available, check out this video about 3D mammography at Emory Healthcare.

For some, the idea of living a normal lifespan with cancer as a chronic disease is a reality.

My hope is that one day, all cancer patients will enjoy a lifetime of survivorship.

Mary Brookhart,
Cancer Survivor

About Mary Brookhart

Mary Brookhart grew up in Ohio before moving to Georgia to get away from the snow. There she enjoyed a 20+ year career in advertising and design. In 2008, looking for something more rewarding, Mary returned to Winship, this time, not as a patient, but as supervisor of business operations for the Emory Glenn Family Breast Center. Besides serving as an advocate for breast cancer patients, Mary coordinates screenings for mammograms and the Emory’s Breast Cancer Seminar for the Newly Diagnosed breast cancer patient. She currently lives in rural Conyers, with her husband of 37 years, and their three horses.

Winship: Year in Review

Winship Cancer Institute of Emory UniversityAs we near the end of 2013, it’s common to reflect on events from the past year, both the challenging and the inspiring. For the Winship Cancer Institute of Emory University, it was an exciting year as strides were made in many areas, including enrolling over 800 patients in clinical trials, breaking ground on the Emory Proton Therapy Center, performing our 4,000th bone marrow and stem cell transplant and continuing to pioneer exciting research discoveries, such as the development of drug therapies aimed to cure brain cancer.

Winship opened its doors in 1937 and was the first center to provide advanced care for cancer patients in the Southeast. Today, as Georgia’s only National Cancer Institute – designated cancer center, Winship is among the nation’s leading institutions as it continues to pursue a future where cancer ceases to exist.

Through the generosity of donations of any size, as well as fundraising events like the Winship Win the Fight 5K, the physicians, staff and researchers at Winship are working harder than ever to achieve that goal for the residents of Georgia and beyond. The video below recaps some of the 2013 achievements as we prepare to welcome 2014 with eagerness and hopefulness!

Running to Carry Forth a Father’s Passion to Make a Difference…

The Winship Win the Fight 5K brings together runners and supporters who participate for a wide variety of reasons. Some run to raise awareness for the importance of cancer funding and research, while others participate to honor the legacy of loved ones who are either currently in the fight against cancer, or those who have lost the battle.

Charles Stevens with daughters

Chandra Stephens-Albright & Charlita Stephens-Walker with their father, Charles.

For Chandra Stephens-Albright and Charlita Stephens-Walker, this weekend’s race is extremely important as the sisters prepare to run for a very special person, their father, Charles R. Stephens. “His name was Charles, his legacy is never giving up, and his leadership was, and remains, in raising funds to do good,” said Chandra about her father who passed away from complications of pancreatic cancer in February 2013.

Charles spent his professional career as a fundraising leader, serving in senior development positions at many educational institutions including his alma mater, Morehouse College. Other places of work included Dillard University, Clark College, Clark Atlanta University, Indiana University Center on Philanthropy and The Interdenominational Theological Center in Atlanta. He also served as the national campaign director for the United Negro College Fund (UNCF).

But Charles’s impact goes far beyond the institutions and organizations for which he served his professional time raising funds. Today, his legacy extends nationally to the individuals who shared his passion for fundraising. As the first African American Chair of the Association of Fundraising Professionals (AFP), a prestigious and international fundraising association, Charles dedicated his life to changing the fundraising industry from the inside out.

A passage from the AFP’s tribute to Charles following his passing captures it all: “Charles’s lifetime passion was to merge philanthropy and diversity (which he saw as nearly the same ideas) and introduce people of diverse backgrounds to the profession he calls ‘inclusive, noble, and worthwhile.’ His efforts changed the way the fundraising community looks at diversity, brought countless women and minorities into the profession and earned him the AFP Chair’s Award for Outstanding Service, an honor that has been granted to less than 20 people since it was instituted in 1982.”

The Chair’s Award was given to Charles during the AFP’s national conference in 2011, which was shortly after Charles had been diagnosed with cancer. Chandra and Charlita accompanied their father to the conference in Chicago, where they learned for the first time the full scope of Charles’s impact on the entire fundraising profession.

“He was a rock star, but to us he had never said so,” said Chandra, a 1985 Emory College alumna. She adds, “My sister and I did not really understand his national contribution until this cancer came along. It is this that establishes the groundwork for our Winship 5K team name – Charles’ Legacy Leaders.”

During his battle with cancer, Charles continued to live life fully by not only continuing to work at his passion, but by taking special vacations and spending quality time with his family, friends and peers.

“I can’t do justice to my father’s spirit with words,” Chandra said. “Not only did he undergo multiple rounds of chemo, but he did so while maintaining his positive spirit and his irrepressible sense of humor. We had two fantastic years to spend with him – years we didn’t think we’d have – in large part due to the fantastic care he got from the team at Winship.”

At the Winship 5K, there is no shortage of inspirational stories like Charles’s to be found. Incredible people like the Stephen sisters are joining in the fight against cancer to honor those who have gone before and made an impact on the world. If you would like to donate to the Winship 5K, contribute to the Charles Legacy Leaders team, or sign-up for the race yourself, please visit our Winship 5K website for more information.

Related Resources: